AltruBio Scores $63M Series A Funding

22 Apr, 2021

AltruBio Scores $63M Series A Funding
Photo by Sven Mieke on Unsplash

– AltruBio from the San Francisco Bay Area is a privately held biotechnology company focused on developing novel therapeutics for the treatment of immunological diseases with high unmet medical needs.
– The company announced the completion of a $63m Series A financing round led by aMoon.

Biotechnology Health Care Medical North America
Crunchbase icon

Content report

The following text will be sent to our editors: